Anika Therapeutics collaborates with University of Liverpool on MSC therapy for osteoarthritis Feb. 2, 2018
FDA approves Avycaz for hospital-acquired and ventilator-associated bacterial pneumonias Feb. 2, 2018
UCB announces launch of Syndesi Therapeutics to develop therapeutics for cognitive disorders Feb. 2, 2018
RSS